26 THE ENZYME TREATMENT OF CANCER
cancer
cells (in the test-tube). Nor have I ever held, as some have done, that because
they supposed, erroneously, that trypsin had some action in “ splitting up” glycogen
or animal starch, that it “ dissolved” glycogen, therefore it should be used in
cancer cases. From the start I wished all the ferments—trypsin, amylopsin, and
steapsin—of the pancreas gland to be used in the injections employed,* The import of trypsin was, of course, clear,
for it was known, since the work of Corvisart and Kühne, to attack and pull
down dead l-albumins, and I anticipated—rightly, in spite of all the contradictions
extant, which are false—that it would, and scientifically regarded must, pull
down the living d-albumins of cancer or trophoblast.** The special reasons for
the employment of very potent injections of amylopsin, which normally converts
starch into a d-sugar, termed “glucose,” came later on. It was found that the
injections first used, which were very deficient in amylopsin, being sometimes,
indeed, almost chemically pure trypsin, produced after some six to eight weeks,
according to the strengths employed, very bad symptoms. These were first
reported to me by French and Italian physicians, and I told them that, as this
treatment followed the lines of what happened in a normal human gestation from
the seventh week onwards, they
* For
evidence of this, reference need only be made to the following fact: Early in
1906, when the London representative of a well-known firm of manufacturing
chemists, specialists in the ferments, called upon me, I requested him to
inform his firm that in my opinion the injections for use in cancer ought to
contain all the ferments.
** The evidences of
the truth of this will be found in the text under the description of the course
of the York case. The like facts were also witnessed in the very similar course
of the Naples case, and these scientific finds are confirmed up to the hilt by
the facts concerning the “liquefaction of cancer ‘‘ in the living human body, as detailed subsequently.